The cost and cost drivers of delivering COVID-19 vaccines in low- and middle-income countries: a bottom-up costing study of rollouts in seven countries

Flavia Moi, Văn Minh Nguyễn, Rachel Archer, Tozé Namalela, Christina Banks, Tarek Hossain, Afroja Yesmin, Cathbert Tumusiime, Charlotte Muheki, Kelsey Vaughan, Elise Smith, Rafael Deo Estanislao, Pierre Z Akilimali, Hong Thi Duong, Chien Chinh Vien, Amélia Dipuve, Pedro Marizane Pota, Monjurul Islam, Paul Kiggundu, Okello Ayen Daniel, Sarah De Los Reyes, Jeremie de Guzman, Christelle Cuevas, Primrose Nakazibwe, Carl Schutte, Minh Van Hoang and Laura Boonstoppel

PLOS ONE, 2026, vol. 21, issue 2, 1-14

Abstract: Introduction: While COVID-19 vaccines were crucial in containing the pandemic, there is limited evidence on the cost of delivering them in low- and middle-income countries. We estimated the cost of delivering COVID-19 vaccines in Bangladesh, Côte d’Ivoire, the Democratic Republic of the Congo, Mozambique, the Philippines, Uganda, and Vietnam. Methods: We retrospectively estimated the financial and economic cost of COVID-19 vaccine delivery from a payer perspective, using a bottom-up approach. Cost data were collected from 290 sites, while qualitative interviews were conducted with 192 key informants. We estimated volume-weighted average costs per dose in 2022 USD, for introduction phases, delivery modalities, and strategies. Results: The financial cost per dose ranged from $0·29-$2·18 across countries, driven by per diem and supplies. The economic cost per dose ranged from $1·14-$9·50, driven by the cost of labor. Newly hired health workers were a cost driver only in the Philippines. The economic delivery cost per dose was inversely correlated with daily vaccine volume delivered at vaccination sites. Similarly, delivering through campaigns came at a lower unit cost than continuous delivery, and when programs scaled up, the cost per dose decreased dramatically. Political prioritization, health workers’ commitment, and volunteers were highlighted as success factors, while resource constraints at implementation level and health workers shortages were flagged as key challenges. Conclusion: Our findings demonstrate how under-resourced health systems managed to deliver massive amounts of vaccines with relatively few resources. However, they also expose significant gaps and inefficiencies, and underscores the need to invest in resilient health systems to improve future pandemic responses.

Date: 2026
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0341964 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 41964&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0341964

DOI: 10.1371/journal.pone.0341964

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().